z-logo
open-access-imgOpen Access
Cyclosporin A affects extracellular matrix synthesis and degradation by mouse MC3T3‐E1 osteoblasts in vitro
Author(s) -
Alessia Fori,
Flavia Cornacchia,
Guy A. Howard,
Bernard A. Roos,
Gary E. Striker,
Liliane J. Striker
Publication year - 2001
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/16.3.500
Subject(s) - extracellular matrix , medicine , osteopenia , in vivo , in vitro , extracellular , osteoblast , microbiology and biotechnology , bone remodeling , matrix (chemical analysis) , osteoporosis , biochemistry , bone mineral , biology , chemistry , chromatography
Immunosuppressant therapy is thought to be a major contributor to post-transplant bone disease. Histological data and serum parameters suggest that Cyclosporin A (CsA) treatment causes osteopenia as a result of an altered bone turnover, but the pathogenic mechanisms of this process remain unclear. We investigate if CsA affects cell turnover and extracellular matrix (ECM) synthesis and degradation in MC3T3-E1 osteoblasts, as a surrogate model for in vivo events.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom